Evidence map›Paper›PMID 41666293›Full record

ArticleACS sensors2026

Inexpensive High-Throughput Multiplexed Cytokine Detection for Tuberculosis Diagnostics Using Amplified Enzymatic Metallization.

Kanz Elkhiyari, Balazs Kaszala, Asma Hashim, Yuvraj Rallapalli, Jeremiah Khayumbi, Joshua Ongalo, Joan Tonui, Cheryl L Day, Aniruddh Sarkar

Abstract read
In one paragraph

Article in ACS sensors, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Kanz ElkhiyariWallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, United States.
Balazs KaszalaWallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, United States.
Asma HashimWallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, United States.ORCID 0009-0004-1688-1495
Yuvraj RallapalliWallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, United States.
Jeremiah KhayumbiCenter for Global Health Research, Kenya Medical Research Institute, Kisumu 40100, Kenya.
Joshua OngaloCenter for Global Health Research, Kenya Medical Research Institute, Kisumu 40100, Kenya.
Joan TonuiCenter for Global Health Research, Kenya Medical Research Institute, Kisumu 40100, Kenya.
Cheryl L DayDepartment of Microbiology and Immunology, School of Medicine, Emory University, Atlanta, Georgia 30322, United States.
Aniruddh SarkarWallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, United States.ORCID 0000-0002-9327-1525

Funding

Emory/Georgia TB Research Advancement Center (TRAC)P30AI168386 · NIAID · EMORY UNIVERSITY · PI Neel Rajnikant Gandhi, Jyothi Rengarajan · 2022 to 2026
$5.8M
NK cell-mediated regulation of T cell immunity in TB/HIV co-infectionR01AI111948 · NIAID · EMORY UNIVERSITY · PI DAY, CHERYL LIANE · 2014 to 2018
$3.7M
Microscale Multiplexed Antibody Fc Profiling and Nanoscale Electronic Detection for Rapid and Scalable Point-of-Care Diagnosis of TuberculosisR01AI182322 · NIAID · GEORGIA INSTITUTE OF TECHNOLOGY · PI Aniruddh Sarkar · 2024 to 2026
$1.1M
NIAID NIH HHS P30 AI168386NIAID NIH HHS R01 AI111948NIAID NIH HHS R01 AI182322
6 · The paper itself

Abstract

Lack of accurate yet inexpensive diagnostics remains a critical bottleneck in the control and elimination of tuberculosis (TB). The interferon-gamma release assay (IGRA), which involves measurement of the release of the cytokine, interferon-gamma (IFN-γ), in blood samples stimulated with Mycobacterium tuberculosis antigens, is used to detect latent TB infection. Use of IGRA in resource-poor settings, in which TB is endemic, is, however, hindered by the need for specialized equipment for sensitive detection of low amounts of cytokine released. Additionally, recent research has shown the advantage of multiplexed detection of other non-IFN-γ cytokines in improving diagnostic accuracy. However, this requires even more expensive instrumentation and there are no inexpensive or point-of-care compatible multiplexed cytokine detection tools available yet. Here, we develop and demonstrate a low-cost, high-throughput, multiplexed cytokine detection platform based on amplified enzymatic silver metallization on a plastic substrate. The assay is performed in microwells formed on a commonly available plastic petri dish, and the dry readout of the deposited silver is obtained using a cellphone camera, thus significantly reducing overall cost and complexity of multiplexed cytokine detection. We demonstrate the ability to measure clinically relevant sub-picomolar levels of multiple cytokines, including IFN-γ, interleukin-2 (IL-2), and tumor necrosis factor alpha (TNF-α) from a small volume (<5μL) of the same blood sample used in an IGRA. Furthermore, we demonstrate the use of this assay to distinguish IGRA+ and IGRA- participant samples from a TB endemic setting.

Indexed as

CytokinesHigh-Throughput Screening AssaysSilverTuberculosisHumansInterferon-gammaInterferon-gamma Release TestsMycobacterium tuberculosisRapid Diagnostic TestsCytokinesInterferon-gammaSilvercytokinediagnosticsmultiplexingpoint-of-caretuberculosis

Identifiers

PMID41666293
PMCPMC12965834

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.